Effect of commercial mouthwashes on SARS-CoV-2 infectious titre. SARS-CoV-2 TCID50 titres were determined after a 1 min treatment with mouthwash (Mw) or PBS at a ratio of 10 : 1 mouthwash:virus. The product corresponding to each data set is given above each graph. For Listerine Total Care, Listerine Advanced Defence Sensitive, OraWize+ and Povident, treatments were additionally performed using a concentrated virus stock. Treatments were performed in triplicate and horizontal bars indicate the mean of triplicates for each condition. The limit of detection for each test, dictated by the cytotoxicity of each product, is indicated with a dashed line on each graph.